Chronic Pain After Intensive Care Unit: Clinical Predictors
NCT ID: NCT07117396
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
92 participants
OBSERVATIONAL
2024-10-11
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Chronic pain is pain that lasts more than 12 weeks and can interfere with your daily life. Studies show that many ICU survivors still experience moderate to severe pain even a year after they go home, especially in the shoulders. This pain is often linked to conditions like severe infections or older age, but it's not yet fully understood.
To help improve care, researchers at Attikon University Hospital in Athens are studying ICU survivors to learn:
How common chronic pain is
Where it appears in the body
How severe it is
How it affects everyday activities
They are also looking at health history, treatments received in the ICU, and lab results to see if any of these are linked to pain after discharge.
If you or your loved one has been in the ICU and experiences ongoing pain, know that you're not alone - and that researchers and doctors are working to better understand and manage this problem.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Post-ICU Pain Study
NCT07180407
ICU Follow-up After Prolonged Intensive Care Stay
NCT04186468
Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region
NCT07290712
ICU Biobank: Understanding Post-Intensive Care Syndrome (PICS)
NCT06671795
Long-term Follow up in Survivors of Critical Illness
NCT04608994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Existing data suggest that up to 73% of ICU survivors report moderate to severe pain one year after discharge, with the shoulder being the most commonly affected anatomical region. Retrospective studies estimate the prevalence of chronic pain among ICU survivors to be as high as 44%. Identified risk factors include advanced age and severe sepsis; however, there is limited evidence regarding the true impact of chronic pain on activities of daily living (ADLs), its intensity, and clinical predictors.
This prospective observational study is conducted at the Intensive Care Unit of Attikon General University Hospital in Athens, Greece, and includes both medical and surgical ICU patients, including cardiothoracic surgery cases. The aim is to assess the prevalence, anatomical distribution, and intensity of chronic pain in ICU survivors, examine its interference with daily functioning, and explore associations between chronic pain and clinical or laboratory data collected during ICU admission, hospitalization, and discharge.
Patients are evaluated at three timepoints: ICU admission, ICU discharge, and three months post-ICU discharge. The inclusion criteria are age ≥18 years and ICU stay of at least 24 hours.
Detailed data collection includes:
Demographics and Lifestyle: Age, sex, educational level, occupation, weight, height, Body Mass Index (BMI), weekly physical activity.
Pain History and Characteristics: Prior history of chronic or acute pain, anatomical localization, intensity with Visual Analogue Scale score (VAS score), and pain qualities assessed using the validated Greek version of the Short-Form McGill Pain Questionnaire.
Medical History: Hypertension, dyslipidemia, arrhythmias, coronary artery disease, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnoea (OSA), chronic kidney disease, Gastro Esophageal Reflux Disease (GERD), peptic ulcer, thyroid disorders, diabetes, stroke, migraine, epilepsy, musculoskeletal/rheumatologic conditions, psychiatric disorders, surgical history, and opioid use.
ICU Parameters: Duration of stay, use of vasopressors, sedatives, opioids, presence of sepsis, mechanical ventilation,Acure Respiratory Distress Syndrome (ARDS), surgical procedures, and regional anesthesia.
Laboratory Data at ICU Admission and Discharge: Hematocrit, hemoglobin, White Blood Cell count (WBC), platelets, International Normalized Ratio (INR), C-reactive protein (CRP) ,fibrinogen, procalcitonin, creatinine, urea, potential of hydrogen (pH), Partial pressure of carbon dioxide (pCO₂), Partial pressure of oxygen (pO₂), Bicarbonate (HCO₃-), potassium, sodium, calcium, phosphorus, magnesium, chloride, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Gamma-Glutamyl Transferase (GGT), Alkaline Phosphatase (ALP), total bilirubin, albumin, and Thyroid-Stimulating Hormone (TSH).
The study's overarching goal is to better characterize the burden of chronic pain among ICU survivors and to inform the development of targeted preventive and therapeutic strategies. Ethical approval has been granted by the Institutional Ethics Committee of Attikon University Hospital, and all participants provide written informed consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A minimum of one day of intensive care unit (ICU) hospitalization
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Attikon Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Milionis Orestis
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Attikon University Hospital
Athens, Attica, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AttikonH 09.10.2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.